Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS
- Conditions
- Peritoneal Dialysis, Continuous Ambulatory
- Interventions
- Procedure: Fluid management based on the clinical information aloneDevice: BCM-guided fluid management
- Registration Number
- NCT01887262
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Bioimpedance-guided fluid management in peritoneal dialysis patients may provide better protection of residual renal function over 1 year period, compared with management guided by clinical information alone - such as blood pressure, body weight, and physician's physical examination.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 108
- age bwten 20 and 75
- peritoneal dialysis > 4 weeks duration
- written consent
- daily urine output > 500 ml
- subjects who are contraindicated to the bioimpedance measurement (pacemaker insertion state, defibrillator state, amputee, prosthesis, metal implants)
- pregnant women
- subjects who are expected to discontinue peritoneal dialysis with one year
- mixed dialysis modality (peritoneal + hemodialysis)
- hypoalbuminemic subjects (serum albumin < 3.3 g/dL)
- high blood pressure (> 160/100 mmHg despite antihypertensive medications)
- severe heart failure (NYHA FC III, or IV)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Fluid management based on the clinical information alone BCM will be measured at the beginning and end of the study, respectively. However, the BCM results will be blinded to the physicians and the control group. The physician will prescribe drugs, PD fluids, and dietary education to the patients based on the clinical information alone - such as blood pressure, edema and body weight. Intervention BCM-guided fluid management Incident peritoneal dialysis (PD) patients who are randomly allocated to BCM-guided fluid management will receive BCM measurement every two months over 1-year period. The BCM results will be notified to the physicians and the participating subjects. Based on the BCM results along with the clinical information such as blood pressure, edema and weight, the physicians will prescribe PD fluid and diuretics, targeting within 1L of overhydration status. They will prescribe dietary education to the patient, if necessary.
- Primary Outcome Measures
Name Time Method delta GFR baseline and 12th month change of glomerular filtration rate from baseline to the 12th month
- Secondary Outcome Measures
Name Time Method GFR at 12th month glomerular filtration rate measured by urine collection, calculated by the mean of creatinine and urea clearance
echocardiographic parameters 12 months period parameters obtained by echocardiographic measurements such as left ventracular mass index (LVMi), E/e' ratio, left vetricular end-diastolic volume (LVEDP), left ventracular ejection fraction (LVEF), left atrial volume indx (LAVI)
time to anuria over 12 months time to the anuric state (urine volume \< 100cc/d)
BP 12th month systolic, diastolic blood pressure, pulse pressure
cardiovascular event over 12 months fatal and nonfatal cardiovascular events - acute myocardial infarction (AMI), stroke, unstable angina, amputation, cardiovascular revascularization
BCM parameters baseline and 12th month parameters measured by body composition monitoring (BCM), such as overhydration(OH), extracellular water (ECW), extracellular-to-intracellular water ratio (ECW/ICW)
Trial Locations
- Locations (1)
Seoul National University Hospital Clinical Trial Center
🇰🇷Seoul, Korea, Republic of